Clinicaltrials feeds. is viagra over the counter in india Org nih clinical trials results via rss main navigation conditions drugs dietary supplements organisations regions imatinib mesylate in patients with refractory desmoplastic small round cell tumors verified by: novartis, december 2010 first received: january 2, 2007 | last updated: december 23, 2010 phase: phase 1/phase 2 | start date: august 2005 overall status: completed | estimated enrollment: 9 brief summary skip to participation criteria official title: “open-label trial of imatinib mesylate in patients with refractory desmoplastic small round cell tumors (dsrct) expressing pdgf-r” an open-label, non-comparative study conducted to investigate the activity and safety of imatinib mesylate in refractory desmoplastic small round cell tumors expressing pdgf-r. Patients will be treated up to 12 months, or to disease progression. Tumor will be evaluated according to recist criteria study type: interventional study design: allocation: non-randomized, endpoint classification: safety/efficacy study, intervention model: single group assignment, masking: open label, primary purpose: treatment study primary completion date: june 2009 interventions used in this clinical trial drug: imatinib mesilate arms, groups and cohorts in this clinical trial experimental: gleevec/glivec outcome measures for this clinical trial primary measures overall tumor response rates time frame: assessed every 3 months safety issue? : yes secondary measures explore how imatinib cooperated with other treatment modatilities time frame: survival data was collected until death safety issue? comparison of viagra viagra or viagra : yes safety and tolerability time frame: safety data collected until patients were no longer in study safety issue? : yes conversion rate to surgical resectability time frame: after best tumor response. best online viagra Safety issue? viagra online without prescription : no mutational analysis of molecular targets of imatinib (at any time during the study) time frame: at any time during the study safety issue? : no criteria for participation in this clinical trial inclusion criteria 1. cheap viagra Patients > 16 years of age. 2. generic viagra Histologically documented diagnosis of dsrct, unresponsive or in no complete remission after any conventional multimodality approach. cheap generic viagra 3. Immunohistochemical documentation of activated pdgf-r expression by tumor 4. comparison of viagra viagra or viagra At least one measurable sit. viagra cost viagra viagra online order